[1]
|
Raychaudhuri, S.P. and Farber, E.M. (2001) The Prevalence of Psoriasis in the World. Journal of the European Academy of Dermatology and Venereology, 15, 16-17. http://dx.doi.org/10.1046/j.1468-3083.2001.00192.x
|
[2]
|
Griffiths, C.E., Christophers, E., Barker, J.N., Chalmers, R.J., Chimenti, S., Krueger, G.G., Leonardi, C., Menter, A., Ortonne, J.P. and Fry, L. (2007) A Classification of Psoriasis Vulgaris According to Phenotype. British Journal of Dermatology, 156, 258-262. http://dx.doi.org/10.1111/j.1365-2133.2006.07675.x
|
[3]
|
Wu, W., Debbaneh, M., Moslehi, H., Koo, J. and Liao, W. (2014) Tonsillectomy as a Treatment for Psoriasis: A Review. The Journal of Dermatological Treatment, 25, 482-486. http://dx.doi.org/10.3109/09546634.2013.848258
|
[4]
|
Griffiths, C.E. and Barker, J.N. (2007) Pathogenesis and Clinical Features of Psoriasis. Lancet, 370, 263-271. http://dx.doi.org/10.1016/S0140-6736(07)61128-3
|
[5]
|
Nestle, F.O., Kaplan, D.H. and Barker, J. (2009) Psoriasis. New England Journal of Medicine, 361, 496-509. http://dx.doi.org/10.1056/NEJMra0804595
|
[6]
|
Wahl, A.K., Gjengedal, E. and Hanestad, B.R. (2002) The Bodily Suffering of Living with Severe Psoriasis: In-Depth Interviews with 22 Hospitalized Patients with Psoriasis. Qualitative Health Research, 12, 250-261. http://dx.doi.org/10.1177/104973202129119874
|
[7]
|
Langley, R.G., Krueger, G.G. and Griffiths, C.E. (2005) Psoriasis: Epidemiology, Clinical Features, and Quality of Life. Annals of the Rheumatic Diseases, 64, ii18-23; Discussion ii24-15. http://dx.doi.org/10.1136/ard.2004.033217
|
[8]
|
Powles, A.V., Baker, B.S., Valdimarsson, H., Hulme, B. and Fry, L. (1990) Four Years of Experience with Cyclosporin A for Psoriasis. British Journal of Dermatology, 122, 13-19. http://dx.doi.org/10.1111/j.1365-2133.1990.tb02877.x
|
[9]
|
McKay, I.A. and Leigh, I.M. (1995) Altered Keratinocyte Growth and Differentiation in Psoriasis. Clinics in Dermatology, 13, 105-114. http://dx.doi.org/10.1016/0738-081X(95)93817-8
|
[10]
|
Bernard, B.A., Asselineau, D., Schaffar-Deshayes, L. and Darmon, M.Y. (1988) Abnormal Sequence of Expression of Differentiation Markers in Psoriatic Epidermis: Inversion of Two Steps in the Differentiation Program? The Journal of Investigative Dermatology, 90, 801-805. http://dx.doi.org/10.1111/1523-1747.ep12462014
|
[11]
|
Giardina, E., Capon, F., De Rosa, M.C., Mango, R., Zambruno, G., Orecchia, A., Chimenti, S., Giardina, B. and Novelli, G. (2004) Characterization of the Loricrin (LOR) Gene as a Positional Candidate for the PSORS4 Psoriasis Susceptibility Locus. Annals of Human Genetics, 68, 639-645. http://dx.doi.org/10.1046/j.1529-8817.2004.00118.x
|
[12]
|
Heidenreich, R., Rocken, M. and Ghoreschi, K. (2009) Angiogenesis Drives Psoriasis Pathogenesis. International Journal of Experimental Pathology, 90, 232-248. http://dx.doi.org/10.1111/j.1365-2613.2009.00669.x
|
[13]
|
Gaspari, A.A. (2006) Innate and Adaptive Immunity and the Pathophysiology of Psoriasis. Journal of the American Academy of Dermatology, 54, S67-S80. http://dx.doi.org/10.1016/j.jaad.2005.10.057
|
[14]
|
Ortonne, J.-P. (1996) Aetiology and Pathogenesis of Psoriasis. British Journal of Dermatology, 135, 1-5. http://dx.doi.org/10.1111/j.1365-2133.1996.tb15660.x
|
[15]
|
Raychaudhuri, S.K., Maverakis, E. and Raychaudhuri, S.P. (2014) Diagnosis and Classification of Psoriasis. Autoimmunity Reviews, 13, 490-495. http://dx.doi.org/10.1016/j.autrev.2014.01.008
|
[16]
|
Naldi, L. and Gambini, D. (2007) The Clinical Spectrum of Psoriasis. Clinics in Dermatology, 25, 510-518. http://dx.doi.org/10.1016/j.clindermatol.2007.08.003
|
[17]
|
Henseler, T. and Christophers, E. (1985) Psoriasis of Early and Late Onset: Characterization of Two Types of Psoriasis Vulgaris. Journal of the American Academy of Dermatology, 13, 450-456. http://dx.doi.org/10.1016/S0190-9622(85)70188-0
|
[18]
|
Pariser, D.M., Bagel, J., Gelfand, J.M., Korman, N.J., Ritchlin, C.T., Strober, B.E., Van Voorhees, A.S., Young, M., Rittenberg, S., Lebwohl, M.G. and Horn, E.J. (2007) National Psoriasis Foundation Clinical Consensus on Disease Severity. Archives of Dermatology, 143, 239-242. http://dx.doi.org/10.1001/archderm.143.2.239
|
[19]
|
Raychaudhuri, S.P. and Gross, J. (2000) A Comparative Study of Pediatric Onset Psoriasis with Adult Onset Psoriasis. Pediatric Dermatology, 17, 174-178.
|
[20]
|
Griffiths, C.E. and Barker, J.N. (2007) Pathogenesis and Clinical Features of Psoriasis. The Lancet, 370, 263-271. http://dx.doi.org/10.1016/S0140-6736(07)61128-3
|
[21]
|
Ayala, F. (2007) Clinical Presentation of Psoriasis. Reumatismo, 59, 40-45.
|
[22]
|
Naldi, L., Peli, L., Parazzini, F. and Carrel, C.F. (2001) Family History of Psoriasis, Stressful Life Events, and Recent Infectious Disease Are Risk Factors for a First Episode of Acute Guttate Psoriasis: Results of A Case-Control Study. Journal of the American Academy of Dermatology, 44, 433-438. http://dx.doi.org/10.1067/mjd.2001.110876
|
[23]
|
Asumalahti, K., Ameen, M., Suomela, S., Hagforsen, E., Michaelsson, G., Evans, J., Munro, M., Veal, C., Allen, M., Leman, J., Burden, A.D., Kirby, B., Connolly, M., Griffiths, C.E., Trembath, R.C., Kere, J., Saarialho-Kere, U. and Barker, J.N. (2003) Genetic Analysis of PSORS1 Distinguishes Guttate Psoriasis and Palmoplantar Pustulosis. The Journal of Investigative Dermatology, 120, 627-632. http://dx.doi.org/10.1046/j.1523-1747.2003.12094.x
|
[24]
|
Weigle, N. and McBane, S. (2013) Psoriasis. American Family Physician, 87, 626-633.
|
[25]
|
Balasubramaniam, P. and Berth-Jones, J. (2004) Erythroderma: 90% Skin Failure. Hospital Medicine, 65, 100-102.
|
[26]
|
Schon, M.P. and Boehncke, W.H. (2005) Psoriasis. The New England Journal of Medicine, 352, 1899-1912. http://dx.doi.org/10.1056/NEJMra041320
|
[27]
|
Chong, H.T., Kopecki, Z. and Cowin, A.J. (2013) Lifting the Silver Flakes: The Pathogenesis and Management of Chronic Plaque Psoriasis. BioMed Research International, 2013, Article ID: 168321. http://dx.doi.org/10.1155/2013/168321
|
[28]
|
Roberson, E.D. and Bowcock, A.M. (2010) Psoriasis Genetics: Breaking the Barrier. Trends in Genetics, 26, 415-423. http://dx.doi.org/10.1016/j.tig.2010.06.006
|
[29]
|
Kim, B.Y., Choi, J.W., Kim, B.R. and Youn, S.W. (2015) Histopathological Findings Are Associated with the Clinical Types of Psoriasis but Not with the Corresponding Lesional Psoriasis Severity Index. Annals of Dermatology, 27, 26-31. http://dx.doi.org/10.5021/ad.2015.27.1.26
|
[30]
|
Langley, R., Krueger, G. and Griffiths, C. (2005) Psoriasis: Epidemiology, Clinical Features, and Quality of Life. Annals of the Rheumatic Diseases, 64, ii18-ii23. http://dx.doi.org/10.1136/ard.2004.033217
|
[31]
|
Lonnberg, A.S., Skov, L., Skytthe, A., Kyvik, K.O., Pedersen, O.B. and Thomsen, S.F. (2013) Heritability of Psoriasis in a Large twin Sample. British Journal of Dermatology, 169, 412-416. http://dx.doi.org/10.1111/bjd.12375
|
[32]
|
Pedersen, O.B., Svendsen, A.J., Ejstrup, L., Skytthe, A. and Junker, P. (2008) On the Heritability of Psoriatic Arthritis. Disease Concordance among Monozygotic and Dizygotic Twins. Annals of the Rheumatic Diseases, 67, 1417-1421. http://dx.doi.org/10.1136/ard.2007.078428
|
[33]
|
Gervin, K., Vigeland, M.D., Mattingsdal, M., Hammero, M., Nygard, H., Olsen, A.O., Brandt, I., Harris, J.R., Undlien, D.E. and Lyle, R. (2012) DNA Methylation and Gene Expression Changes in Monozygotic Twins Discordant for Psoriasis: Identification of Epigenetically Dysregulated Genes. PLoS Genetics, 8, e1002454. http://dx.doi.org/10.1371/journal.pgen.1002454
|
[34]
|
Monteleone, G., Pallone, F., MacDonald, T.T., Chimenti, S. and Costanzo, A. (2011) Psoriasis: From Pathogenesis to Novel Therapeutic Approaches. Clinical Science, 120, 1-11.
|
[35]
|
Lesueur, F., Lefevre, C., Has, C., Guilloud-Bataille, M., Oudot, T., Mahe, E., Lahfa, M., Mansouri, S., Mosharraf-Olmolk, H., Sobel, E., Heath, S., Lathrop, M., Dizier, M.H., Prud’Homme, J.F. and Fischer, J. (2007) Confirmation of Psoriasis Susceptibility Loci on Chromosome 6p21 and 20p13 in French Families. The Journal of Investigative Dermatology, 127, 1403-1409. http://dx.doi.org/10.1038/sj.jid.5700749
|
[36]
|
Gandhi, G., Buttar, B.S., Albert, L., Hasan, Q. and Aggarwal, R.K. (2011) Psoriasis-Associated Genetic Polymorphism in North Indian Population in the CCHCR1 Gene and in a Genomic Segment Flanking the HLA-C Region. Disease Markers, 31, 361-370. http://dx.doi.org/10.1155/2011/682782
|
[37]
|
Tsoi, L.C., Spain, S.L., Knight, J., Ellinghaus, E., Stuart, P.E., Capon, F., Ding, J., Li, Y., Tejasvi, T., Gudjonsson, J.E., Kang, H.M., Allen, M.H., McManus, R., Novelli, G., Samuelsson, L., Schalkwijk, J., Stahle, M., Burden, A.D., Smith, C.H., Cork, M.J., Estivill, X., Bowcock, A.M., Krueger, G.G., Weger, W., Worthington, J., Tazi-Ahnini, R., Nestle, F.O., Hayday, A., Hoffmann, P., Winkelmann, J., Wijmenga, C., Langford, C., Edkins, S., Andrews, R., Blackburn, H., Strange, A., Band, G., Pearson, R.D., Vukcevic, D., Spencer, C.C., Deloukas, P., Mrowietz, U., Schreiber, S., Weidinger, S., Koks, S., Kingo, K., Esko, T., Metspalu, A., Lim, H.W., Voorhees, J.J., Weichenthal, M., Wichmann, H.E., Chandran, V., Rosen, C.F., Rahman, P., Gladman, D.D., Griffiths, C.E., Reis, A., Kere, J., Collaborative Association Study of Psoriasis (CASP), Genetic Analysis of Psoriasis Consortium, Psoriasis Association Genetics Extension, Wellcome Trust Case Control Consortium 2, Nair, R.P., Franke, A., Barker, J.N., Abecasis, G.R., Elder, J.T. and Trembath, R.C. (2012) Identification of 15 New Psoriasis Susceptibility Loci Highlights the Role of Innate Immunity. Nature Genetics, 44 1341-1348. http://dx.doi.org/10.1038/ng.2467
|
[38]
|
Rottman, J.B., Smith, T.L., Ganley, K.G., Kikuchi, T. and Krueger, J.G. (2001) Potential Role of the Chemokine Receptors CXCR3, CCR4, and the Integrin alphaEbeta7 in the Pathogenesis of Psoriasis Vulgaris. Laboratory Investigation, 81, 335-347.
|
[39]
|
Oestreicher, J.L., Walters, I.B., Kikuchi, T., Gilleaudeau, P., Surette, J., Schwertschlag, U., Dorner, A.J., Krueger, J.G. and Trepicchio, W.L. (2001) Molecular Classification of Psoriasis Disease-Associated Genes through Pharmacogenomic Expression Profiling. The Pharmacogenomics Journal, 1, 272-287. http://dx.doi.org/10.1038/sj.tpj.6500067
|
[40]
|
Koks, S., Kingo, K., Vabrit, K., Ratsep, R., Karelson, M., Silm, H. and Vasar, E. (2005) Possible Relations between the Polymorphisms of the Cytokines IL-19, IL-20 and IL-24 and Plaque-Type Psoriasis. Genes and Immunity, 6, 407-415. http://dx.doi.org/10.1038/sj.gene.6364216
|
[41]
|
Koks, S., Kingo, K., Ratsep, R., Karelson, M., Silm, H. and Vasar, E. (2004) Combined Haplotype Analysis of the Interleukin-19 and -20 Genes: Relationship to Plaque-Type Psoriasis. Genes and Immunity, 5, 662-667. http://dx.doi.org/10.1038/sj.gene.6364141
|
[42]
|
Hendriks, A.G., van der Velden, H.M., Wolberink, E.A., Seyger, M.M., Schalkwijk, J., Zeeuwen, P.L., de Jong, E.M., Pasch, M.C., van Erp, P.E. and van de Kerkhof, P.C. (2014) The Effect of Adalimumab on Key Drivers in the Pathogenesis of Psoriasis. British Journal of Dermatology, 170, 571-580. http://dx.doi.org/10.1111/bjd.12705
|
[43]
|
Sofen, H., Smith, S., Matheson, R.T., Leonardi, C.L., Calderon, C., Brodmerkel, C., Li, K., Campbell, K., Marciniak Jr., S.J., Wasfi, Y., Wang, Y., Szapary, P. and Krueger, J.G. (2014) Guselkumab (an IL-23-Specific mAb) Demonstrates Clinical and Molecular Response in Patients with Moderate-to-Severe Psoriasis. The Journal of Allergy and Clinical Immunology, 133, 1032-1040. http://dx.doi.org/10.1016/j.jaci.2014.01.025
|
[44]
|
Johnston, A., Guzman, A.M., Swindell, W.R., Wang, F., Kang, S. and Gudjonsson, J.E. (2014) Early Tissue Responses in Psoriasis to the Antitumour Necrosis Factor-Alpha Biologic Etanercept Suggest Reduced Interleukin-17 Receptor Expression and Signalling. British Journal of Dermatology, 171, 97-107. http://dx.doi.org/10.1111/bjd.12937
|
[45]
|
Russell, C.B., Rand, H., Bigler, J., Kerkof, K., Timour, M., Bautista, E., Krueger, J.G., Salinger, D.H., Welcher, A.A. and Martin, D.A. (2014) Gene Expression Profiles Normalized in Psoriatic Skin by Treatment with Brodalumab, a Human Anti-IL-17 Receptor Monoclonal Antibody. Journal of Immunology, 192, 3828-3836.
|
[46]
|
Nejentsev, S., Walker, N., Riches, D., Egholm, M. and Todd, J.A. (2009) Rare Variants of IFIH1, a Gene Implicated in Antiviral Responses, Protect against Type 1 Diabetes. Science, 324, 387-389. http://dx.doi.org/10.1126/science.1167728
|
[47]
|
York, I.A., Chang, S.C., Saric, T., Keys, J.A., Favreau, J.M., Goldberg, A.L. and Rock, K.L. (2002) The ER Aminopeptidase ERAP1 Enhances or Limits Antigen Presentation by Trimming Epitopes to 8 - 9 Residues. Nature Immunology, 3, 1177-1184. http://dx.doi.org/10.1038/ni860
|
[48]
|
Levine, D. and Gottlieb, A. (2009) Evaluation and Management of Psoriasis: An Internist’s Guide. The Medical Clinics of North America, 93, 1291-1303. http://dx.doi.org/10.1016/j.mcna.2009.08.003
|
[49]
|
Patel, R.V., Shelling, M.L., Prodanovich, S., Federman, D.G. and Kirsner, R.S. (2011) Psoriasis and Vascular Disease-Risk Factors and Outcomes: A Systematic Review of the Literature. Journal of General Internal Medicine, 26, 1036-1049. http://dx.doi.org/10.1007/s11606-011-1698-5
|
[50]
|
Prieto-Perez, R., Solano-Lopez, G., Cabaleiro, T., Roman, M., Ochoa, D., Talegon, M., Baniandres, O., Lopez Estebaranz, J.L., de la Cueva, P., Dauden, E. and Abad-Santos, F. (2015) The Polymorphism rs763780 in the IL-17F Gene Is Associated with Response to Biological Drugs in Patients with Psoriasis. Pharmacogenomics, 16, 1723-1731. http://dx.doi.org/10.2217/pgs.15.107
|
[51]
|
Oppmann, B., Lesley, R., Blom, B., Timans, J.C., Xu, Y., Hunte, B., Vega, F., Yu, N., Wang, J., Singh, K., Zonin, F., Vaisberg, E., Churakova, T., Liu, M., Gorman, D., Wagner, J., Zurawski, S., Liu, Y., Abrams, J.S., Moore, K.W., Rennick, D., de Waal-Malefyt, R., Hannum, C., Bazan, J.F and Kastelein, R.A. (2000) Novel p19 Protein Engages IL-12p40 to Form a Cytokine, IL-23, with Biological Activities Similar as Well as Distinct from IL-12. Immunity, 13, 715-725. http://dx.doi.org/10.1016/S1074-7613(00)00070-4
|
[52]
|
Cargill, M., Schrodi, S.J., Chang, M., Garcia, V.E., Brandon, R., Callis, K.P., Matsunami, N., Ardlie, K.G., Civello, D., Catanese, J.J., Leong, D.U., Panko, J.M., McAllister, L.B., Hansen, C.B., Papenfuss, J., Prescott, S.M., White, T.J., Leppert, M.F., Krueger, G.G. and Begovich, A.B. (2007) A Large-Scale Genetic Association Study Confirms IL12B and Leads to the Identification of IL23R as Psoriasis-Risk Genes. American Journal of Human Genetics, 80, 273-290. http://dx.doi.org/10.1086/511051
|
[53]
|
Li, B., Tsoi, L.C., Swindell, W.R., Gudjonsson, J.E., Tejasvi, T., Johnston, A., Ding, J., Stuart, P.E., Xing, X., Kochkodan, J.J., Voorhees, J.J., Kang, H.M., Nair, R.P., Abecasis, G.R. and Elder, J.T. (2014) Transcriptome Analysis of Psoriasis in a large Case-Control Sample: RNA-seq Provides Insights into Disease Mechanisms. The Journal of Investigative Dermatology, 134, 1828-1838. http://dx.doi.org/10.1038/jid.2014.28
|
[54]
|
Jokai, H., Szakonyi, J., Kontar, O., Marschalko, M., Szalai, K., Karpati, S. and Hollo, P. (2013) Impact of Effective tumor Necrosis Factor-alfa Inhibitor Treatment on Arterial Intima-Media Thickness in Psoriasis: Results of a Pilot Study. Journal of the American Academy of Dermatology, 69, 523-529. http://dx.doi.org/10.1016/j.jaad.2013.06.019
|
[55]
|
Eiris, N., Santos-Juanes, J., Coto-Segura, P., Gomez, J., Alvarez, V., Morales, B., Queiro, R., Diaz, M., Corao, A.I., Lopez-Corte, K. and Coto, E. (2012) Resequencing of the IL12B Gene in Psoriasis Patients with the rs6887695/ rs3212227 risk Genotypes. Cytokine, 60, 27-29. http://dx.doi.org/10.1016/j.cyto.2012.05.030
|
[56]
|
Johnston, A., Xing, X., Swindell, W.R., Kochkodan, J., Riblett, M., Nair, R.P., Stuart, P.E., Ding, J., Voorhees, J.J., Elder, J.T. and Gudjonsson, J.E. (2013) Susceptibility-Associated Genetic Variation at IL12B Enhances Th1 Polarization in Psoriasis. Human Molecular Genetics, 22, 1807-1815. http://dx.doi.org/10.1093/hmg/ddt034
|
[57]
|
Oostveen, A.M., Bergboer, J.G., van de Kerkhof, P.C., Zeeuwen, P.L., de Jong, E.M., Schalkwijk, J. and Seyger, M.M. (2014) Genotype-Phenotype Correlations in a Prospective Cohort Study of Paediatric Plaque Psoriasis: Lack of Correlation between HLA-C*06 and Family History of Psoriasis. Acta Dermato-Venereologica, 94, 667-671. http://dx.doi.org/10.2340/00015555-1810
|
[58]
|
Sandoval-Talamantes, A.K., Brito-Luna, M.J., Fafutis-Morris, M., Villanueva-Quintero, D.G., Graciano-Machuca, O., Ramirez-Duenas, M.G. and Alvarado-Navarro, A. (2015) The 3’UTR 1188A/C Polymorphism of IL-12p40 Is Not Associated with Susceptibility for Developing Plaque Psoriasis in Mestizo Population from Western Mexico. Immunology Letters, 163, 221-226. http://dx.doi.org/10.1016/j.imlet.2014.10.004
|
[59]
|
Yao, F., Yue, M., Zhang, C., Zuo, X., Zheng, X., Zhang, A., Wang, Z., Liu, S., Li, H., Meng, L., Zeng, M., Fan, X., Sun, L. and Zhang, X. (2015) A Genetic Coding Variant rs72474224 in GJB2 Is Associated with Clinical Features of Psoriasis Vulgaris in a Chinese Han Population. Tissue Antigens, 86, 134-138. http://dx.doi.org/10.1111/tan.12595
|
[60]
|
Wu, Y., Lu, Z., Chen, Y., Xue, F., Chen, X., Pan, M. and Zheng, J. (2013) Association of IL-12B Gene rs6887695 Polymorphism with Hereditary Susceptibility and Clinical Characterization of Psoriasis Vulgaris in the Chinese Han Population. Archives of Dermatological Research, 305, 477-482. http://dx.doi.org/10.1007/s00403-013-1342-9
|
[61]
|
Hebert, H.L., Bowes, J., Smith, R.L., Flynn, E., Parslew, R., Alsharqi, A., McHugh, N.J., Barker, J.N., Griffiths, C.E., Barton, A. and Warren, R.B. (2015) Identification of Loci Associated with Late-Onset Psoriasis Using Dense Genotyping of Immune-Related Regions. British Journal of Dermatology, 172, 933-939. http://dx.doi.org/10.1111/bjd.13340
|
[62]
|
Allen, M.H., Ameen, H., Veal, C., Evans, J., Ramrakha-Jones, V.S., Marsland, A.M., Burden, A.D., Griffiths, C.E., Trembath, R.C. and Barker, J.N. (2005) The Major Psoriasis Susceptibility Locus PSORS1 Is Not a Risk Factor for Late-Onset Psoriasis. The Journal of Investigative Dermatology, 124, 103-106. http://dx.doi.org/10.1111/j.0022-202X.2004.23511.x
|
[63]
|
Christensen, T.E., Callis, K.P., Papenfuss, J., Hoffman, M.S., Hansen, C.B., Wong, B., Panko, J.M. and Krueger, G.G. (2006) Observations of Psoriasis in the Absence of Therapeutic Intervention Identifies Two Unappreciated Morphologic Variants, Thin-Plaque and Thick-Plaque Psoriasis, and Their Associated Phenotypes. The Journal of Investigative Dermatology, 126, 2397-2403. http://dx.doi.org/10.1038/sj.jid.5700489
|
[64]
|
Karabacak, E., Aydin, E., Ozcan, O., Dogan, B., Gultepe, M., Cosar, A. and Muftuoglu, T. (2014) Methylenetetrahydrofolate Reductase (MTHFR) 677C>T Gene Polymorphism as a Possible Factor for Reducing Clinical Severity of Psoriasis. International Journal of Clinical and Experimental Medicine, 7, 697-702.
|
[65]
|
Baiqiu, W., Songbin, F., Guiyin, Z. and Pu, L. (2000) Study of the Relationship between Psoriasis and the Polymorphic Site C677T of Methylenetetrahydrofolate Reductase. Chinese Medical Sciences Journal, 15, 119-120.
|
[66]
|
Naldi, L. (2004) Epidemiology of Psoriasis. Current Drug Targets—Inflammation & Allergy, 3, 121-128. http://dx.doi.org/10.2174/1568010043343958
|
[67]
|
Yanbaeva, D.G., Dentener, M.A., Creutzberg, E.C., Wesseling, G. and Wouters, E.F. (2007) Systemic Effects of Smoking. Chest, 131, 1557-1566. http://dx.doi.org/10.1378/chest.06-2179
|
[68]
|
Armstrong, A.W., Harskamp, C.T., Dhillon, J.S. and Armstrong, E.J. (2014) Psoriasis and Smoking: A Systematic Review and Meta-Analysis. British Journal of Dermatology, 170, 304-314. http://dx.doi.org/10.1111/bjd.12670
|
[69]
|
Sopori, M. (2002) Effects of Cigarette Smoke on the Immune System. Nature Reviews Immunology, 2, 372-377. http://dx.doi.org/10.1038/nri803
|
[70]
|
McAllister-Sistilli, C.G., Caggiula, A.R., Knopf, S., Rose, C.A., Miller, A.L. and Donny, E.C. (1998) The Effects of Nicotine on the Immune System. Psychoneuroendocrinology, 23, 175-187. http://dx.doi.org/10.1016/S0306-4530(97)00080-2
|
[71]
|
Armstrong, A.W., Armstrong, E.J., Fuller, E.N., Sockolov, M.E. and Voyles, S.V. (2011) Smoking and Pathogenesis of Psoriasis: A Review of Oxidative, Inflammatory and Genetic Mechanisms. British Journal of Dermatology, 165, 1162-1168. http://dx.doi.org/10.1111/j.1365-2133.2011.10526.x
|
[72]
|
Malhotra, S. and Mehta, V. (2008) Role of Stressful Life Events in Induction or Exacerbation of Psoriasis and Chronic Urticaria. Indian Journal of Dermatology, Venereology, and Leprology, 74, 594-599. http://dx.doi.org/10.4103/0378-6323.45100
|
[73]
|
Evers, A., Verhoeven, E., Kraaimaat, F., De Jong, E., De Brouwer, S., Schalkwijk, J., Sweep, F. and Van De Kerkhof, P. (2010) How Stress Gets under the Skin: Cortisol and Stress Reactivity in Psoriasis. British Journal of Dermatology, 163, 986-991. http://dx.doi.org/10.1111/j.1365-2133.2010.09984.x
|
[74]
|
Kunz-Ebrecht, S.R., Mohamed-Ali, V., Feldman, P.J., Kirschbaum, C. and Steptoe, A. (2003) Cortisol Responses to Mild Psychological Stress Are Inversely Associated with Proinflammatory Cytokines. Brain, Behavior, and Immunity, 17, 373-383. http://dx.doi.org/10.1016/S0889-1591(03)00029-1
|
[75]
|
Weinstein, G. and Gottlieb, A. (2003) Therapy of Moderate-to-Severe-Psoriasis. CRC Press, Boca Raton.
|
[76]
|
Sagi, L. and Trau, H. (2011) The Koebner Phenomenon. Clinics in Dermatology, 29, 231-236. http://dx.doi.org/10.1016/j.clindermatol.2010.09.014
|
[77]
|
Balato, N., Di Costanzo, L., Patruno, C., Patri, A. and Ayala, F. (2013) Effect of Weather and Environmental Factors on the Clinical Course of Psoriasis. Occupational and Environmental Medicine, 70, 600. http://dx.doi.org/10.1136/oemed-2013-101505
|
[78]
|
Fry, L. and Baker, B.S. (2007) Triggering Psoriasis: The Role of Infections and Medications. Clinics in Dermatology, 25, 606-615. http://dx.doi.org/10.1016/j.clindermatol.2007.08.015
|
[79]
|
Brien, M.O. and Koo, J. (2006) The Mechanism of Lithium and Beta-Blocking Agents in Inducing and Exacerbating Psoriasis. Journal of Drugs in Dermatology, 5, 426-432.
|
[80]
|
Wolf, R. and Schiavo, A.L. (1997) Is Transglutaminase the Mediator between Antimalarial Drugs and Psoriasis? International Journal of Dermatology, 36, 10-13.
|
[81]
|
Telfer, N.R., Chalmers, R.J., Whale, K. and Colman, G. (1992) The Role of Streptococcal Infection in the Initiation of Guttate Psoriasis. Archives of Dermatology, 128, 39-42. http://dx.doi.org/10.1001/archderm.1992.01680110049004
|
[82]
|
Leung, D.Y., Walsh, P., Giorno, R. and Norris, D.A. (1993) A Potential Role for Superantigens in the Pathogenesis of Psoriasis. Journal of Investigative Dermatology, 100, 225-228.
|
[83]
|
Rajappa, M., Rathika, S., Munisamy, M., Chandrashekar, L. and Thappa, D.M. (2015) Effect of Treatment with Methotrexate and Coal Tar on Adipokine Levels and Indices of Insulin Resistance and Sensitivity in Patients with Psoriasis Vulgaris. Journal of the European Academy of Dermatology and Venereology, 29, 69-76. http://dx.doi.org/10.1111/jdv.12451
|
[84]
|
Shaharyar, S., Warraich, H., McEvoy, J.W., Oni, E., Ali, S.S., Karim, A., Jamal, O., Blaha, M.J., Blumenthal, R.S., Fialkow, J., Cury, R., Budoff, M.J., Agatston, A.A. and Nasir, K. (2014) Subclinical Cardiovascular Disease in Plaque Psoriasis: Association or Causal Link? Atherosclerosis, 232, 72-78. http://dx.doi.org/10.1016/j.atherosclerosis.2013.10.023
|
[85]
|
Miller, I.M., Ellervik, C., Yazdanyar, S. and Jemec, G.B. (2013) Meta-Analysis of Psoriasis, Cardiovascular Disease, and Associated Risk Factors. Journal of the American Academy of Dermatology, 69, 1014-1024. http://dx.doi.org/10.1016/j.jaad.2013.06.053
|
[86]
|
Nijsten, T. and Wakkee, M. (2009) Complexity of the Association between Psoriasis and Comorbidities. The Journal of Investigative Dermatology, 129, 1601-1603. http://dx.doi.org/10.1038/jid.2009.55
|
[87]
|
Sabat, R., Philipp, S., Hoflich, C., Kreutzer, S., Wallace, E., Asadullah, K., Volk, H.D., Sterry, W. and Wolk, K. (2007) Immunopathogenesis of Psoriasis. Experimental Dermatology, 16, 779-798. http://dx.doi.org/10.1111/j.1600-0625.2007.00629.x
|
[88]
|
Mease, P.J., Signorovitch, J., Yu, A.P., Wu, E.Q., Gupta, S.R., Bao, Y. and Mulani, P.M. (2010) Impact of Adalimumab on Symptoms of Psoriatic Arthritis in Patients with Moderate to Severe Psoriasis: A Pooled Analysis of Randomized Clinical Trials. Dermatology, 220, 1-7. http://dx.doi.org/10.1159/000260371
|
[89]
|
Gisondi, P., Targher, G., Zoppini, G. and Girolomoni, G. (2009) Non-Alcoholic Fatty Liver Disease in Patients with Chronic Plaque Psoriasis. Journal of Hepatology, 51, 758-764. http://dx.doi.org/10.1016/j.jhep.2009.04.020
|
[90]
|
Gisondi, P., Cotena, C., Tessari, G. and Girolomoni, G. (2008) Anti-Tumour Necrosis Factor-α Therapy Increases Body Weight in Patients with Chronic Plaque Psoriasis: A Retrospective Cohort Study. Journal of the European Academy of Dermatology and Venereology, 22, 341-344. http://dx.doi.org/10.1111/j.1468-3083.2007.02429.x
|
[91]
|
Pathirana, D., Ormerod, A.D., Saiag, P., Smith, C., Spuls, P.I., Nast, A., Barker, J., Bos, J.D., Burmester, G.R., Chimenti, S., Dubertret, L., Eberlein, B., Erdmann, R., Ferguson, J., Girolomoni, G., Gisondi, P., Giunta, A., Griffiths, C., Honigsmann, H., Hussain, M., Jobling, R., Karvonen, S.L., Kemeny, L., Kopp, I., Leonardi, C., Maccarone, M., Menter, A., Mrowietz, U., Naldi, L., Nijsten, T., Ortonne, J.P., Orzechowski, H.D., Rantanen, T., Reich, K., Reytan, N., Richards, H., Thio, H.B., van de Kerkhof, P. and Rzany, B. (2009) European S3-Guidelines on the Systemic Treatment of Psoriasis Vulgaris. Journal of the European Academy of Dermatology and Venereology, 23, 1-70. http://dx.doi.org/10.1111/j.1468-3083.2009.03389.x
|
[92]
|
Saurat, J.H., Stingl, G., Dubertret, L., Papp, K., Langley, R., Ortonne, J.P., Unnebrink, K., Kaul, M. and Camez, A. (2008) Efficacy and Safety Results from the Randomized Controlled Comparative Study of Adalimumab vs. Methotrexate vs. Placebo in Patients with Psoriasis (CHAMPION). British Journal of Dermatology, 158, 558-566. http://dx.doi.org/10.1111/j.1365-2133.2007.08315.x
|
[93]
|
Strober, B.E. and Menon, K. (2005) Folate Supplementation during Methotrexate Therapy for Patients with Psoriasis. Journal of the American Academy of Dermatology, 53, 652-659. http://dx.doi.org/10.1016/j.jaad.2005.06.036
|
[94]
|
Gaeta, M., Castelvecchio, S., Ricci, C., Pigatto, P., Pellissero, G. and Cappato, R. (2013) Role of Psoriasis as Independent Predictor of Cardiovascular Disease: A Meta-Regression Analysis. International Journal of Cardiology, 168, 2282-2288. http://dx.doi.org/10.1016/j.ijcard.2013.01.197
|
[95]
|
Yiu, K.H., Yeung, C.K., Chan, H.T., Wong, R., Tam, S., Lam, K.F., Yan, G., Yue, W., Chan, H. and Tse, H.F. (2011) Increased Arterial Stiffness in Patients with Psoriasis Is Associated with Active Systemic Inflammation. British Journal of Dermatology, 164, 514-520. http://dx.doi.org/10.1111/j.1365-2133.2010.10107.x
|
[96]
|
Kaye, J., Li, L. and Jick, S. (2008) Incidence of Risk Factors for Myocardial Infarction and Other Vascular Diseases in Patients with Psoriasis. British Journal of Dermatology, 159, 895-902. http://dx.doi.org/10.1111/j.1365-2133.2008.08707.x
|
[97]
|
Ludwig, R.J., Herzog, C., Rostock, A., Ochsendorf, F.R., Zollner, T.M., Thaci, D., Kaufmann, R., Vogl, T. and Boehncke, W.H. (2007) Psoriasis: A Possible Risk Factor for Development of Coronary Artery Calcification. British Journal of Dermatology, 156, 271-276. http://dx.doi.org/10.1111/j.1365-2133.2006.07562.x
|
[98]
|
Sarwar, A., Shaw, L.J., Shapiro, M.D., Blankstein, R., Hoffman, U., Cury, R.C., Abbara, S., Brady, T.J., Budoff, M.J. and Blumenthal, R.S. (2009) Diagnostic and Prognostic Value of Absence of Coronary Artery Calcification. JACC: Cardiovascular Imaging, 2, 675-688. http://dx.doi.org/10.1016/j.jcmg.2008.12.031
|
[99]
|
Torres, T., Machado, S., Mendonca, D. and Selores, M. (2014) Cardiovascular Comorbidities in Childhood Psoriasis. European Journal of Dermatology, 24, 229-235.
|
[100]
|
Groeneveld, M., Huang-Doran, I. and Semple, R. (2012) Adiponectin and Leptin in Human Severe Insulin Resistance—Diagnostic Utility and Biological Insights. Biochimie, 94, 2172-2179. http://dx.doi.org/10.1016/j.biochi.2012.01.021
|
[101]
|
Bastard, J.P., Maachi, M., Lagathu, C., Kim, M.J., Caron, M., Vidal, H., Capeau, J. and Feve, B. (2006) Recent Advances in the Relationship between Obesity, Inflammation, and Insulin Resistance. European Cytokine Network, 17, 4-12.
|
[102]
|
Golden, J.B., McCormick, T.S. and Ward, N.L. (2013) IL-17 in Psoriasis: Implications for Therapy and Cardiovascular Co-Morbidities. Cytokine, 62, 195-201. http://dx.doi.org/10.1016/j.cyto.2013.03.013
|
[103]
|
Arias-Santiago, S., Orgaz-Molina, J., Castellote-Caballero, L., Arrabal-Polo, M.A., Garcia-Rodriguez, S., Perandres-Lopez, R., Ruiz, J.C., Naranjo-Sintes, R., Zubiaur, M., Sancho, J. and Buendia-Eisman, A. (2012) Atheroma Plaque, Metabolic Syndrome and Inflammation in Patients with Psoriasis. European Journal of Dermatology, 22, 337-344.
|
[104]
|
Votrubova, J., Juzlova, K., Smerhovsky, Z., Fialova, J., Gopfertova, D., Vojackova, N. and Hercogova, J. (2014) Risk Factors for Comorbidities in Czech Psoriatic Patients: Results of a Hospital-Based Case-Control Study. Biomedical Papers of the Medical Faculty of the University Palacky, 158, 288-294.
|
[105]
|
Boehncke, W.H., Boehncke, S. and Schon, M.P. (2010) Managing Comorbid Disease in Patients with Psoriasis. BMJ, 340, b5666. http://dx.doi.org/10.1136/bmj.b5666
|
[106]
|
Alberti, K.G., Zimmet, P. and Shaw, J. (2005) The Metabolic Syndrome—A New Worldwide Definition. The Lancet, 366, 1059-1062. http://dx.doi.org/10.1016/S0140-6736(05)67402-8
|
[107]
|
Ridker, P.M., Fonseca, F.A., Genest, J., Gotto, A.M., Kastelein, J.J., Khurmi, N.S., Koenig, W., Libby, P., Lorenzatti, A.J. and Nordestgaard, B.G. (2007) Baseline Characteristics of Participants in the JUPITER Trial, a Randomized Placebo-Controlled Primary Prevention Trial of Statin Therapy among Individuals with Low Low-Density Lipoprotein Cholesterol and Elevated High-Sensitivity C-Reactive Protein. The American Journal of Cardiology, 100, 1659-1664. http://dx.doi.org/10.1016/j.amjcard.2007.09.072
|
[108]
|
Akcali, C., Buyukcelik, B., Kirtak, N. and Inaloz, S. (2014) Clinical and Laboratory Parameters Associated with Metabolic Syndrome in Turkish Patients with Psoriasis. The Journal of International Medical Research, 42, 386-394. http://dx.doi.org/10.1177/0300060513502891
|
[109]
|
Lowes, M.A., Bowcock, A.M. and Krueger, J.G. (2007) Pathogenesis and Therapy of Psoriasis. Nature, 445, 866-873. http://dx.doi.org/10.1038/nature05663
|
[110]
|
Anderson, K.S., Petersson, S., Wong, J., Shubbar, E., Lokko, N.N., Carlstrom, M. and Enerback, C. (2010) Elevation of Serum Epidermal Growth Factor and Interleukin 1 Receptor Antagonist in Active Psoriasis Vulgaris. British Journal of Dermatology, 163, 1085-1089. http://dx.doi.org/10.1111/j.1365-2133.2010.09990.x
|
[111]
|
Gerdes, S., Osadtschy, S., Rostami-Yazdi, M., Buhles, N., Weichenthal, M. and Mrowietz, U. (2012) Leptin, Adiponectin, Visfatin and Retinol-Binding Protein-4—Mediators of Comorbidities in Patients with Psoriasis? Experimental Dermatology, 21, 43-47. http://dx.doi.org/10.1111/j.1600-0625.2011.01402.x
|
[112]
|
Boehncke, W.H., Boehncke, S., Tobin, A.M. and Kirby, B. (2011) The “Psoriatic March”: A Concept of How Severe Psoriasis May Drive Cardiovascular Comorbidity. Experimental Dermatology, 20, 303-307. http://dx.doi.org/10.1111/j.1600-0625.2011.01261.x
|
[113]
|
Corbetta, S., Angioni, R., Cattaneo, A., Beck-Peccoz, P. and Spada, A. (2006) Effects of Retinoid Therapy on Insulin Sensitivity, Lipid Profile and Circulating Adipocytokines. European Journal of Endocrinology, 154, 83-86. http://dx.doi.org/10.1530/eje.1.02057
|
[114]
|
Gisondi, P., Cazzaniga, S., Chimenti, S., Giannetti, A., Maccarone, M., Picardo, M., Girolomoni, G. and Naldi, L. (2013) Metabolic Abnormalities Associated with Initiation of Systemic Treatment for Psoriasis: Evidence from the Italian Psocare Registry. Journal of the European Academy of Dermatology and Venereology, 27, e30-e41. http://dx.doi.org/10.1111/j.1468-3083.2012.04450.x
|
[115]
|
Ahmad, Z., Akhtar, S.J., Maan, M.A., Khalid, U. and Hussain, A. (2014) Comparison of Mean Platelet Volume in Patients with Psoriasis and Healthy Individuals. Journal of Pakistan Association of Dermatologists, 24, 1-3.
|
[116]
|
Saleh, H., Attia, E., Onsy, A., Saad, A. and Abd Ellah, M. (2013) Platelet Activation: A Link between Psoriasis per se and Subclinical Atherosclerosis—A Case-Control Study. British Journal of Dermatology, 169, 68-75. http://dx.doi.org/10.1111/bjd.12285
|
[117]
|
Davidovici, B.B., Sullivan-Whalen, M.M., Gilleaudeau, P. and Krueger, J.G. (2010) Differing Effect of Systemic Anti Psoriasis Therapies on Platelet Physiology—A Case Report and Review of Literature. BMC Dermatology, 10, 2. http://dx.doi.org/10.1186/1471-5945-10-2
|
[118]
|
Magen, E., Mishal, J., Zeldin, Y., Feldman, V., Kidon, M., Schlesinger, M. and Sthoeger, Z. (2010) Increased Mean Platelet Volume and C-Reactive Protein Levels in Patients with Chronic Urticaria with a Positive Autologous Serum Skin Test. The American Journal of the Medical Sciences, 339, 504-508. http://dx.doi.org/10.1097/MAJ.0b013e3181db6ed5
|
[119]
|
Marzano, A.V., Tedeschi, A., Berti, E., Fanoni, D., Crosti, C. and Cugno, M. (2011) Activation of Coagulation in Bullous Pemphigoid and Other Eosinophil-Related Inflammatory Skin Diseases. Clinical and Experimental Immunology, 165, 44-50. http://dx.doi.org/10.1111/j.1365-2249.2011.04391.x
|
[120]
|
Kolliker Frers, R.A., Bisoendial, R.J., Montoya, S.F., Kerzkerg, E., Castilla, R., Tak, P.P., Milei, J. and Capani, F. (2015) Psoriasis and Cardiovascular Risk: Immune-Mediated Crosstalk between Metabolic, Vascular and Autoimmune Inflammation. IJC Metabolic & Endocrine, 6, 43-54. http://dx.doi.org/10.1016/j.ijcme.2015.01.005
|
[121]
|
Gottlieb, A.B. and Dann, F. (2009) Comorbidities in Patients with Psoriasis. The American Journal of Medicine, 122, 1150.e1151-1150.e1159. http://dx.doi.org/10.1016/j.amjmed.2009.06.021
|
[122]
|
Gelfand, J.M., Shin, D.B., Neimann, A.L., Wang, X., Margolis, D.J. and Troxel, A.B. (2006) The Risk of Lymphoma in Patients with Psoriasis. The Journal of Investigative Dermatology, 126, 2194-2201. http://dx.doi.org/10.1038/sj.jid.5700410
|
[123]
|
Pouplard, C., Brenaut, E., Horreau, C., Barnetche, T., Misery, L., Richard, M.A., Aractingi, S., Aubin, F., Cribier, B., Joly, P., Jullien, D., Le Maitre, M., Ortonne, J.P. and Paul, C. (2013) Risk of Cancer in Psoriasis: A Systematic Review and Meta-Analysis of Epidemiological Studies. Journal of the European Academy of Dermatology and Venereology, 27, 36-46. http://dx.doi.org/10.1111/jdv.12165
|
[124]
|
Skudutyte-Rysstad, R., Slevolden, E.M., Hansen, B.F., Sandvik, L. and Preus, H.R. (2014) Association between Moderate to Severe Psoriasis and Periodontitis in a Scandinavian Population. BMC Oral Health, 14, 139. http://dx.doi.org/10.1186/1472-6831-14-139
|
[125]
|
Chiu, H.Y., Huang, H.L., Li, C.H., Yin, Y.J., Chen, H.A., Hsu, S.T., Lin, S.J., Tsai, T.F. and Ho, S.Y. (2015) Increased Risk of Glomerulonephritis and Chronic Kidney Disease in Relation to the Severity of Psoriasis, Concomitant Medication, and Comorbidity: A Nationwide Population-Based Cohort Study. British Journal of Dermatology, 173, 146-154. http://dx.doi.org/10.1111/bjd.13599
|